Tulip Cell & Gene Tech Expo April 2026: Commercial Readiness

In the high-stakes environment of life sciences, relying on paper-based systems for batch processes, lab operations, and line clearances often leads to data silos and lengthy review cycles. While traditional Manufacturing Execution Systems (MES) offer a digital alternative, they frequently require months of requirement gathering and years of expensive customization. A more agile approach involves utilizing no-code platforms that empower teams to build and scale solutions—such as digital logbooks and review-by-exception apps—in a fraction of the time, often reaching validation readiness within just sixty days.

By adopting an open ecosystem, these platforms integrate seamlessly with existing ERP, LIMS, and quality systems, filling functional gaps without requiring a total infrastructure overhaul. Advanced features now include AI-driven tools that can convert standard operating procedure (SOP) PDFs into draft applications or utilize natural language queries to extract actionable insights from production data. Moving from "paper to glass" is only the beginning; the ultimate goal is a connected facility where automated workflows and machine connectivity drive continuous operational improvement and significantly reduce quality review timelines.

About Tulip

Tulip is a leading frontline operations platform that helps manufacturers connect people, machines, and systems into a single, flexible environment. By combining no-code app building, real-time data, and integrations, Tulip enables teams to streamline workflows, improve quality, and drive continuous operational improvement at scale. A spinoff out of MIT, the company is headquartered in Somerville, MA, with offices in Germany, Hungary, Singapore, Tel Aviv, and Tokyo.